President Trump made the announcement during a May 31 ceremony to sign the “right-to-try” bill into law.
“You’re going to have some big news. I think we’re going to have some of the big drug companies in two weeks said they’re going to announce, because of what we did, they’re going to announce voluntary massive drops in prices,” he said, according to Reuters.
The president did not say which companies would lower prices or specify the extent of the expected price reductions. An HHS spokesperson told Reuters the agency would not elaborate on President Trump’s comments “because it didn’t want to get ahead of any announcements,” according to the report.
More articles on supply chain:
How Amazon’s latest patent would let customers interact with delivery drones
Allergan recalls 170k birth control samples with placebo pills in wrong order
10 most-read supply chain stories in May
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.